January 1, 2026, marks a significant shift, as the Inflation Reduction Act (IRA)-driven Maximum Fair Price (MFP) pricing and the 340B Rebate Model Pilot Program launch side by side for the first time. This dual-model environment introduces new reimbursement rules, data-reporting demands, and cash-flow considerations for pharmacies and health-system leaders. Learn More >



